aluates Reports

$ 0.0

Automative

Global Biosimilar Testing Service Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-2K2400

Global Biosimilar Testing Service Market Insights Forecast to 2028

BUY CHAPTERS

Global Biosimilar Testing Service Market Research Report 2025

Code: QYRE-Auto-2K2400

Report

June 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Charles River Laboratories International

Merck

PPD

LAB Holdings

Eurofins Scientific

Intertek

SGS Ltd

Profacgen

Antibody Analytics

Kymos Pharma Services

Medicilon

Pacific Biolabs

Sartorius

Biosimilar Testing Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biosimilar Testing Service Market

The global market for Biosimilar Testing Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and also offer therapeutic options. Biosimilar have a unique properties, which is used to study the biological functions and structures complexity of the sample.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Biosimilar Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Testing Service.

The Biosimilar Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Testing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosimilar Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosimilar Testing Service Market Report

Report Metric	Details
Report Name	Biosimilar Testing Service Market
CAGR	5%
Segment by Type	Pharmacokinetic Assay Tiered Immunogenicity Testing Others
Segment by Application	Hospitals Pharmaceutical Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Charles River Laboratories International, Merck, PPD, LAB Holdings, Eurofins Scientific, Intertek, SGS, Profacgen, Antibody Analytics, Kymos Pharma Services, Medicilon, Pacific BioLabs, Sartorius
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biosimilar Testing Service Market report?

Ans: The main players in the Biosimilar Testing Service Market are Charles River Laboratories International, Merck, PPD, LAB Holdings, Eurofins Scientific, Intertek, SGS, Profacgen, Antibody Analytics, Kymos Pharma Services, Medicilon, Pacific BioLabs, Sartorius

What are the Application segmentation covered in the Biosimilar Testing Service Market report?

Ans: The Applications covered in the Biosimilar Testing Service Market report are Hospitals, Pharmaceutical Companies, Others

What are the Type segmentation covered in the Biosimilar Testing Service Market report?

Ans: The Types covered in the Biosimilar Testing Service Market report are Pharmacokinetic Assay, Tiered Immunogenicity Testing, Others

Recommended Reports

Biopharmaceutical Testing

Clinical and Drug Services

Biosimilar and Biologics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosimilar Testing Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pharmacokinetic Assay

1.2.3 Tiered Immunogenicity Testing

1.2.4 Others

1.3 Market by Application

1.3.1 Global Biosimilar Testing Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Pharmaceutical Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosimilar Testing Service Market Perspective (2020-2031)

2.2 Global Biosimilar Testing Service Growth Trends by Region

2.2.1 Global Biosimilar Testing Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Biosimilar Testing Service Historic Market Size by Region (2020-2025)

2.2.3 Biosimilar Testing Service Forecasted Market Size by Region (2026-2031)

2.3 Biosimilar Testing Service Market Dynamics

2.3.1 Biosimilar Testing Service Industry Trends

2.3.2 Biosimilar Testing Service Market Drivers

2.3.3 Biosimilar Testing Service Market Challenges

2.3.4 Biosimilar Testing Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biosimilar Testing Service Players by Revenue

3.1.1 Global Top Biosimilar Testing Service Players by Revenue (2020-2025)

3.1.2 Global Biosimilar Testing Service Revenue Market Share by Players (2020-2025)

3.2 Global Biosimilar Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Biosimilar Testing Service Revenue

3.4 Global Biosimilar Testing Service Market Concentration Ratio

3.4.1 Global Biosimilar Testing Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing Service Revenue in 2024

3.5 Global Key Players of Biosimilar Testing Service Head office and Area Served

3.6 Global Key Players of Biosimilar Testing Service, Product and Application

3.7 Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar Testing Service Breakdown Data by Type

4.1 Global Biosimilar Testing Service Historic Market Size by Type (2020-2025)

4.2 Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031)

5 Biosimilar Testing Service Breakdown Data by Application

5.1 Global Biosimilar Testing Service Historic Market Size by Application (2020-2025)

5.2 Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Biosimilar Testing Service Market Size (2020-2031)

6.2 North America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Biosimilar Testing Service Market Size by Country (2020-2025)

6.4 North America Biosimilar Testing Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biosimilar Testing Service Market Size (2020-2031)

7.2 Europe Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Biosimilar Testing Service Market Size by Country (2020-2025)

7.4 Europe Biosimilar Testing Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biosimilar Testing Service Market Size (2020-2031)

8.2 Asia-Pacific Biosimilar Testing Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biosimilar Testing Service Market Size (2020-2031)

9.2 Latin America Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Biosimilar Testing Service Market Size by Country (2020-2025)

9.4 Latin America Biosimilar Testing Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biosimilar Testing Service Market Size (2020-2031)

10.2 Middle East & Africa Biosimilar Testing Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Charles River Laboratories International

11.1.1 Charles River Laboratories International Company Details

11.1.2 Charles River Laboratories International Business Overview

11.1.3 Charles River Laboratories International Biosimilar Testing Service Introduction

11.1.4 Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025)

11.1.5 Charles River Laboratories International Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Biosimilar Testing Service Introduction

11.2.4 Merck Revenue in Biosimilar Testing Service Business (2020-2025)

11.2.5 Merck Recent Development

11.3 PPD

11.3.1 PPD Company Details

11.3.2 PPD Business Overview

11.3.3 PPD Biosimilar Testing Service Introduction

11.3.4 PPD Revenue in Biosimilar Testing Service Business (2020-2025)

11.3.5 PPD Recent Development

11.4 LAB Holdings

11.4.1 LAB Holdings Company Details

11.4.2 LAB Holdings Business Overview

11.4.3 LAB Holdings Biosimilar Testing Service Introduction

11.4.4 LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025)

11.4.5 LAB Holdings Recent Development

11.5 Eurofins Scientific

11.5.1 Eurofins Scientific Company Details

11.5.2 Eurofins Scientific Business Overview

11.5.3 Eurofins Scientific Biosimilar Testing Service Introduction

11.5.4 Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025)

11.5.5 Eurofins Scientific Recent Development

11.6 Intertek

11.6.1 Intertek Company Details

11.6.2 Intertek Business Overview

11.6.3 Intertek Biosimilar Testing Service Introduction

11.6.4 Intertek Revenue in Biosimilar Testing Service Business (2020-2025)

11.6.5 Intertek Recent Development

11.7 SGS

11.7.1 SGS Company Details

11.7.2 SGS Business Overview

11.7.3 SGS Biosimilar Testing Service Introduction

11.7.4 SGS Revenue in Biosimilar Testing Service Business (2020-2025)

11.7.5 SGS Recent Development

11.8 Profacgen

11.8.1 Profacgen Company Details

11.8.2 Profacgen Business Overview

11.8.3 Profacgen Biosimilar Testing Service Introduction

11.8.4 Profacgen Revenue in Biosimilar Testing Service Business (2020-2025)

11.8.5 Profacgen Recent Development

11.9 Antibody Analytics

11.9.1 Antibody Analytics Company Details

11.9.2 Antibody Analytics Business Overview

11.9.3 Antibody Analytics Biosimilar Testing Service Introduction

11.9.4 Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025)

11.9.5 Antibody Analytics Recent Development

11.10 Kymos Pharma Services

11.10.1 Kymos Pharma Services Company Details

11.10.2 Kymos Pharma Services Business Overview

11.10.3 Kymos Pharma Services Biosimilar Testing Service Introduction

11.10.4 Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025)

11.10.5 Kymos Pharma Services Recent Development

11.11 Medicilon

11.11.1 Medicilon Company Details

11.11.2 Medicilon Business Overview

11.11.3 Medicilon Biosimilar Testing Service Introduction

11.11.4 Medicilon Revenue in Biosimilar Testing Service Business (2020-2025)

11.11.5 Medicilon Recent Development

11.12 Pacific BioLabs

11.12.1 Pacific BioLabs Company Details

11.12.2 Pacific BioLabs Business Overview

11.12.3 Pacific BioLabs Biosimilar Testing Service Introduction

11.12.4 Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025)

11.12.5 Pacific BioLabs Recent Development

11.13 Sartorius

11.13.1 Sartorius Company Details

11.13.2 Sartorius Business Overview

11.13.3 Sartorius Biosimilar Testing Service Introduction

11.13.4 Sartorius Revenue in Biosimilar Testing Service Business (2020-2025)

11.13.5 Sartorius Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Charles River Laboratories International

Merck

PPD

LAB Holdings

Eurofins Scientific

Intertek

SGS Ltd

Profacgen

Antibody Analytics

Kymos Pharma Services

Medicilon

Pacific Biolabs

Sartorius

List of Tables

Table 1. Global Biosimilar Testing Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pharmacokinetic Assay

Table 3. Key Players of Tiered Immunogenicity Testing

Table 4. Key Players of Others

Table 5. Global Biosimilar Testing Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Biosimilar Testing Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Biosimilar Testing Service Market Share by Region (2020-2025)

Table 9. Global Biosimilar Testing Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Biosimilar Testing Service Market Share by Region (2026-2031)

Table 11. Biosimilar Testing Service Market Trends

Table 12. Biosimilar Testing Service Market Drivers

Table 13. Biosimilar Testing Service Market Challenges

Table 14. Biosimilar Testing Service Market Restraints

Table 15. Global Biosimilar Testing Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Biosimilar Testing Service Market Share by Players (2020-2025)

Table 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)

Table 18. Ranking of Global Top Biosimilar Testing Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Biosimilar Testing Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Biosimilar Testing Service, Headquarters and Area Served

Table 21. Global Key Players of Biosimilar Testing Service, Product and Application

Table 22. Global Key Players of Biosimilar Testing Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Biosimilar Testing Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Biosimilar Testing Service Revenue Market Share by Type (2020-2025)

Table 26. Global Biosimilar Testing Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Biosimilar Testing Service Revenue Market Share by Type (2026-2031)

Table 28. Global Biosimilar Testing Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Biosimilar Testing Service Revenue Market Share by Application (2020-2025)

Table 30. Global Biosimilar Testing Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Biosimilar Testing Service Revenue Market Share by Application (2026-2031)

Table 32. North America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Biosimilar Testing Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Biosimilar Testing Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Biosimilar Testing Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Biosimilar Testing Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Biosimilar Testing Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Biosimilar Testing Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. Charles River Laboratories International Company Details

Table 48. Charles River Laboratories International Business Overview

Table 49. Charles River Laboratories International Biosimilar Testing Service Product

Table 50. Charles River Laboratories International Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 51. Charles River Laboratories International Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Biosimilar Testing Service Product

Table 55. Merck Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. PPD Company Details

Table 58. PPD Business Overview

Table 59. PPD Biosimilar Testing Service Product

Table 60. PPD Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 61. PPD Recent Development

Table 62. LAB Holdings Company Details

Table 63. LAB Holdings Business Overview

Table 64. LAB Holdings Biosimilar Testing Service Product

Table 65. LAB Holdings Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 66. LAB Holdings Recent Development

Table 67. Eurofins Scientific Company Details

Table 68. Eurofins Scientific Business Overview

Table 69. Eurofins Scientific Biosimilar Testing Service Product

Table 70. Eurofins Scientific Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 71. Eurofins Scientific Recent Development

Table 72. Intertek Company Details

Table 73. Intertek Business Overview

Table 74. Intertek Biosimilar Testing Service Product

Table 75. Intertek Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 76. Intertek Recent Development

Table 77. SGS Company Details

Table 78. SGS Business Overview

Table 79. SGS Biosimilar Testing Service Product

Table 80. SGS Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 81. SGS Recent Development

Table 82. Profacgen Company Details

Table 83. Profacgen Business Overview

Table 84. Profacgen Biosimilar Testing Service Product

Table 85. Profacgen Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 86. Profacgen Recent Development

Table 87. Antibody Analytics Company Details

Table 88. Antibody Analytics Business Overview

Table 89. Antibody Analytics Biosimilar Testing Service Product

Table 90. Antibody Analytics Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 91. Antibody Analytics Recent Development

Table 92. Kymos Pharma Services Company Details

Table 93. Kymos Pharma Services Business Overview

Table 94. Kymos Pharma Services Biosimilar Testing Service Product

Table 95. Kymos Pharma Services Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 96. Kymos Pharma Services Recent Development

Table 97. Medicilon Company Details

Table 98. Medicilon Business Overview

Table 99. Medicilon Biosimilar Testing Service Product

Table 100. Medicilon Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 101. Medicilon Recent Development

Table 102. Pacific BioLabs Company Details

Table 103. Pacific BioLabs Business Overview

Table 104. Pacific BioLabs Biosimilar Testing Service Product

Table 105. Pacific BioLabs Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 106. Pacific BioLabs Recent Development

Table 107. Sartorius Company Details

Table 108. Sartorius Business Overview

Table 109. Sartorius Biosimilar Testing Service Product

Table 110. Sartorius Revenue in Biosimilar Testing Service Business (2020-2025) & (US$ Million)

Table 111. Sartorius Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Biosimilar Testing Service Picture

Figure 2. Global Biosimilar Testing Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biosimilar Testing Service Market Share by Type: 2024 VS 2031

Figure 4. Pharmacokinetic Assay Features

Figure 5. Tiered Immunogenicity Testing Features

Figure 6. Others Features

Figure 7. Global Biosimilar Testing Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Biosimilar Testing Service Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Pharmaceutical Companies Case Studies

Figure 11. Others Case Studies

Figure 12. Biosimilar Testing Service Report Years Considered

Figure 13. Global Biosimilar Testing Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Biosimilar Testing Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Biosimilar Testing Service Market Share by Region: 2024 VS 2031

Figure 16. Global Biosimilar Testing Service Market Share by Players in 2024

Figure 17. Global Top Biosimilar Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Biosimilar Testing Service Revenue in 2024

Figure 19. North America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Biosimilar Testing Service Market Share by Country (2020-2031)

Figure 21. United States Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Biosimilar Testing Service Market Share by Country (2020-2031)

Figure 25. Germany Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Biosimilar Testing Service Market Share by Region (2020-2031)

Figure 33. China Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Biosimilar Testing Service Market Share by Country (2020-2031)

Figure 41. Mexico Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Biosimilar Testing Service Market Share by Country (2020-2031)

Figure 45. Turkey Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Biosimilar Testing Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Charles River Laboratories International Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 50. PPD Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 51. LAB Holdings Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 52. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 53. Intertek Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 54. SGS Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 55. Profacgen Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 56. Antibody Analytics Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 57. Kymos Pharma Services Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 58. Medicilon Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 59. Pacific BioLabs Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 60. Sartorius Revenue Growth Rate in Biosimilar Testing Service Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Biopharmaceutical Analytical Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biosimilar Drug Market

Immunology Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biological Safety Testing Service Market Research Report 2025

Bevacizumab Biosimilar Market

Pharmaceutical Stability Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biomedical Testing Services Market Research Report 2025

Protein Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Antibody Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Glycosylated Proteins Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cetuximab Biosimilar Market Research Report 2025

Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions